Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

Climb Bio Stock News

CLYMNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$1.27

0.000.00%

Pre-Market: 4:24 PM EDT

Q4 2024 Earnings were released on Tue Mar 25th, after the market close

Climb Bio (CLYM) Forecast

News

Earnings Climb Bio (CLYM) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest Climb Bio Stock News | NASDAQ:CLYM | Benzinga

Get the latest news on Climb Bio stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Climb Bio performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Tuesday, March 25, 2025

Climb Bio Expects Cash Runway Through 2027
Benzinga Newsdesk
Climb Bio Q4 2024 GAAP EPS $(0.13) Beats $(0....
Benzinga Newsdesk

Wednesday, January 15, 2025

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights

Friday, January 10, 2025

Climb Bio Entered Technology Transfer And Exc...
Benzinga Newsdesk

Thursday, January 09, 2025

Climb Bio To Make Upfront Cash Payment Of $9M...
Benzinga Newsdesk
Climb Bio Enters Exclusive License Deal With ...
Benzinga Newsdesk

Tuesday, November 12, 2024

Climb Bio Q3 EPS $(0.13) Up From $(0.15) YoY
Benzinga Newsdesk

Monday, November 11, 2024

Climb Bio shares are trading higher. The comp...
Benzinga Newsdesk
Climb Bio Appoints Douglas E. Williams As Cha...
Benzinga Newsdesk

Tuesday, October 15, 2024

Climb Bio Completes Transition To Immune-medi...
Benzinga Newsdesk

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Popular Channels

PreMarket Playbook
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved